Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TELA Bio (TELA) EBIT Margin (2018 - 2025)

Historic EBIT Margin for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to 36.51%.

  • Bio's EBIT Margin rose 128900.0% to 36.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 46.02%, marking a year-over-year increase of 93900.0%. This contributed to the annual value of 49.23% for FY2024, which is 261700.0% up from last year.
  • Bio's EBIT Margin amounted to 36.51% in Q3 2025, which was up 128900.0% from 44.96% recorded in Q2 2025.
  • In the past 5 years, Bio's EBIT Margin ranged from a high of 29.07% in Q1 2024 and a low of 123.69% during Q1 2021
  • In the last 5 years, Bio's EBIT Margin had a median value of 72.23% in 2023 and averaged 75.36%.
  • In the last 5 years, Bio's EBIT Margin soared by 654300bps in 2024 and then plummeted by -274800bps in 2025.
  • Quarter analysis of 5 years shows Bio's EBIT Margin stood at 91.4% in 2021, then rose by 11bps to 81.22% in 2022, then grew by 11bps to 72.23% in 2023, then skyrocketed by 34bps to 47.33% in 2024, then grew by 23bps to 36.51% in 2025.
  • Its EBIT Margin stands at 36.51% for Q3 2025, versus 44.96% for Q2 2025 and 56.54% for Q1 2025.